Seattle biotech company Blaze Bioscience has received Fast Track designation from the FDA for a clinical program evaluating tozuleristide. Update, April 8: Blaze… Read More Editor’s note: The GeekWire ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results